Вісник проблем біології і медицини (Dec 2020)

POSSIBILITIES OF DYSBIOTIC CHANGES CORRECTION IN PATIENTS WITH JOINTS AND SPINE INJURIES AND INFLAMMATORY BOWEL DISEASES

  • Zhdan V. M.,
  • Kyrian O. A.,
  • Babanina M. Yu.,
  • Shilkina L. M.,
  • Katerenchuk O. I.

DOI
https://doi.org/10.29254/2077-4214-2020-4-158-131-136
Journal volume & issue
no. 4
pp. 131 – 136

Abstract

Read online

The goal of our research was to study the efficiency of safe probiotic Bacillus clausii administration in correction of dysbiotic changes in patients with inflammatory bowel diseases when they also have extraintestinal joints and spine injuries. 56 patients with inflammatory bowel diseases who also had extraintestinal injuries of joints and spine were examined and treated. The average age of the patients was 37,4±5,1 years. The duration of the disease was no less than 6 months. The patients were divided into two groups. The first group consisted of 26 (46,4%) patients who were prescribed the Bacillus clausii probiotic in addition to the standard medication. There were 30 (53,6%) patients in the second group who underwent the standard drug treatment without probiotics, prebiotics, and symbiotic. The activity of the inflammatory bowel diseases with extraintestinal injuries was evaluated using non-specific markers such as C-reactive protein, leukocytosis, thrombocytosis, erythrocyte sedimentation rate and considering the calprotectin quantitative content. The profile of the colonic microbiota was studied to determine the efficiency of the Bacillus clausii probiotic in patients with inflammatory bowel diseases and extraintestinal injuries of joints and spine. All patients of the first and second groups had colonic dysbiosis with an increase of the opportunistic microflora and reduction of Lactobacillus. In the first group of patients with inflammatory bowel diseases and extraintestinal joints and spine injuries who received the Bacillus clausii probiotic treatment pain intensity and flatulence (p<0,05) decrease was detected on the 28 day of treatment. Significant reduction of Enteroccocus, Klebsiella, Citrobacter amount (p<0,01) as well as increase of Lactobacillus amount (p<0,05) in the colonic microflora in the first group of patients was detected. These results give an opportunity to recommend the Bacillus clausii probiotic for treatment of patients with inflammatory bowel diseases and extraintestinal joints and spine injuries.

Keywords